Uncovering the signaling mechanisms allowing medulloblastoma progenitor cells to orchestrate tumor relapse |
Medical University of South Carolina / Jezabel Rodriguez Blanco, PhD |
'A' Award Grants |
2023 |
South Carolina |
Engineering the Lymph Node Environment with Therapeutic Vaccine Depots to Combat Neuroblastoma |
University of Maryland, College Park / Christopher Jewell, PhD |
'A' Award Grants |
2013 |
Maryland |
Inside-Out Immunotherapy: Combating Neuroblastoma via Nanoparticle-Directed Reprogramming of the Tumor Microenvironment |
Vanderbilt University Medical Center / John Wilson, PhD |
'A' Award Grants |
2015 |
Tennessee |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
The Role of the Innate Immune System in Immune Dysregulation following CART |
Children’s Hospital of Philadelphia / Caroline Diorio, MD |
'A' Award Grants |
2023 |
Pennsylvania |
Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma |
Baylor College of Medicine / Robin Parihar, MD/PhD |
'A' Award Grants |
2021 |
Texas |
Reversing mSWI/SNF (BAF) Complex Misassembly and Genomic Targeting in Human Synovial Sarcoma |
Dana-Farber Cancer Institute / Cigall Kadoch, PhD |
'A' Award Grants |
2017 |
Massachusetts |
Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma |
University of California San Francisco / William Clay Gustafson, MD, PhD |
'A' Award Grants |
2011 |
California |
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities |
Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD |
'A' Award Grants |
2019 |
Massachusetts |
BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia |
Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD |
'A' Award Grants |
2012 |
New York |